Eurofins · 1 day ago
Scientist - Cell and Molecular Biology
Eurofins Scientific is an international life sciences company providing analytical testing services across multiple industries. The Scientist role involves performing a wide range of analyses in molecular, cell biology, and virology test areas, as well as reviewing data and validating new analytical processes.
BiotechnologyGeneticsHealth CareLife SciencePharmaceutical
Responsibilities
Perform a wide range of analyses (routine and non-routine) primarily but not limited to the molecular, cell biology, and virology test areas of Biopharmaceutical Services
Review and evaluate raw data for acceptability
Set up and validate new analytical or related processes used by the department
Willingness to learn molecular biology technology
Qualification
Required
Bachelor's degree in biology, molecular or cell biology, or other related degree concentration, or equivalent directly-related experience (two years of directly related industry experience is equivalent to one full-time year of college in related major)
Authorization to work in the United States indefinitely without restriction or sponsorship
Strong computer, scientific, and organizational skills
Excellent communication (oral and written) and attention to detail
Ability to work independently and as part of a team, self-motivation, adaptability, and a positive attitude
Ability to learn new techniques, perform multiple tasks simultaneously, keep accurate records, follow instructions, and comply with company policies
PCR technique exposure/experience
Benefits
Comprehensive medical coverage
Life and disability insurance
401(k) with company match
Paid holidays and vacation
Personal days
Dental and vision options
Company
Eurofins
Eurofins provides testing and support services to the pharmaceutical, food, environmental, and consumer products industries.
Funding
Current Stage
Public CompanyTotal Funding
$1.05B2025-06-26Post Ipo Debt· $586.37M
2025-03-27Post Ipo Debt· $431.4M
2021-10-22Grant· $30M
Recent News
2025-12-16
Business Wire
2025-12-08
Company data provided by crunchbase